Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
David Mitchell, founder of an advocacy group called Patients for Affordable Drugs, said in a statement that the $475,000 cost is "excessive" and claims the federal government spent $200 million in early research on CAR-T therapy before Novartis purchased rights to the treatment.
Free market in action, as usual.
by gk (gk (gk quattro due due sette @gmail.com)) on Thu Oct 5th, 2017 at 03:41:32 PM EST
[ Parent ]
The evidence is all around us.

Diversity is the key to economic and political evolution.
by Cat on Thu Oct 5th, 2017 at 03:45:34 PM EST
[ Parent ]
For the US market the most effective attack on Novartis  would almost certainly be to seize upon their 'pagan' symbol, note they associate with 'witch doctors' and have a foreign domicile and then claim they are the spearhead for a conspiracy including space aliens to alter the DNA of US citizens, their vital essence' so as to make them more compatible with our new alien overlords.

Arguing that the price is excessive because Novartis purchased the rights for $200 million of research paid for by taxpayers will fail. Don't you know? "Government can't do anything right!" So the popular view will be that government squandered $200 million and it took a private company go get a profit out of it. And children with cancer? Pfft. As if they matter.  

"It is not necessary to have hope in order to persevere."

by ARGeezer (ARGeezer a in a circle eurotrib daught com) on Thu Oct 5th, 2017 at 05:14:48 PM EST
[ Parent ]


Occasional Series